BenchSci closes $95-million CAD Series D to expand AI drug-d

Toronto-based BenchSci, which helps pharmaceutical firms accelerate R&D using AI, has announced $95 million CAD in Series D funding.

Related Keywords

Canada , Anthony Woolf , Liran Belenzon , Astrazeneca , Generation Investment Management , Toronto Based Benchsci , Inovia Capital , Golden Ventures , F Prime Capital , Unlike Deep Genomics , Eli Lilly , Investment Management , Benchsci , Ai , Drug Discovery , Ftcv , Funding , Healthtech , Toronto ,